Kontaktujte nás | Jazyk: čeština English
| dc.title | What is uric acid concentration in urine in patients with uric acid kidney stones? - a case study | en |
| dc.contributor.author | Šálek, Tomáš | |
| dc.contributor.author | Musil, Pavel | |
| dc.contributor.author | Zlatníková, Irena | |
| dc.relation.ispartof | Biochemia Medica | |
| dc.identifier.issn | 1330-0962 Scopus Sources, Sherpa/RoMEO, JCR | |
| dc.date.issued | 2025 | |
| utb.relation.volume | 35 | |
| utb.relation.issue | 3 | |
| dc.citation.spage | 31001 | |
| dc.type | article | |
| dc.language.iso | en | |
| dc.identifier.doi | 10.11613/BM.2025.031001 | |
| dc.relation.uri | https://www.biochemia-medica.com/en/journal/35/3/10.11613/BM.2025.031001/fullArticle | |
| dc.relation.uri | https://www.biochemia-medica.com/assets/images/upload/xml_tif/bm-35-3-031001.pdf | |
| dc.subject | nephrolithiasis | en |
| dc.subject | specimen preservation | en |
| dc.subject | uric acid | en |
| dc.subject | urine | en |
| dc.subject | urine specimen collection | en |
| dc.subject | citrate potassium | en |
| dc.subject | potassium citrate | en |
| dc.subject | case report | en |
| dc.subject | drug therapy | en |
| dc.subject | human | en |
| dc.subject | male | en |
| dc.subject | middle aged | en |
| dc.subject | pH | en |
| dc.subject | humans | en |
| dc.subject | hydrogen-ion concentration | en |
| dc.subject | kidney calculi | en |
| dc.subject | malepotassium citrate | en |
| dc.description.abstract | This case report describes a patient with uric acid kidney stones. Alkalization therapy using mainly potassium citrate is the first-choice treatment. When hyperuricosuria > 4 mmol/24 hours is present, xanthine oxidase inhibitors are added. It implies that accurate urine uric acid measurement is of high importance. Uric acid was measured in a 24-hour collection and a second-morning sample. Urine uric acid was measured after sample alkalization to pH > 6.5 and heating to 56 °C for 10 minutes, and for educational reasons without sample treatment. The uric acid excretion in the sample without alkalization in the 24-hour collection was 2.436 mmol, after alkalization, the excretion was 4.650 mmol/24 hours. Sample alkalization led to a prescription for xanthine oxidase inhibitor medication that is indicated as the second-line therapy when hyperuricosuria > 4 mmol/24 hours is present. This case study shows how the correct preanalytical phase is essential for medical decision-making. This record is sourced from MEDLINE/PubMed, a database of the U.S. National Library of Medicine | en |
| utb.faculty | Faculty of Humanities | |
| dc.identifier.uri | http://hdl.handle.net/10563/1012525 | |
| utb.identifier.scopus | 2-s2.0-105013687779 | |
| utb.identifier.pubmed | 40822842 | |
| utb.source | j-scopus | |
| dc.date.accessioned | 2025-10-16T07:25:46Z | |
| dc.date.available | 2025-10-16T07:25:46Z | |
| dc.rights | Attribution 4.0 International | |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| dc.rights.access | openAccess | |
| utb.ou | Department of Health Care Sciences | |
| utb.contributor.internalauthor | Šálek, Tomáš | |
| utb.fulltext.sponsorship | - | |
| utb.scopus.affiliation | Tomas Bata Hospital in Zlín, Zlin, Czech Republic; Tomas Bata University in Zlin, Zlin, Czech Republic | |
| utb.fulltext.projects | - |